| Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction S Wang, Z He, X Wang, H Li, XS Liu eLife, 2019 | 260 | 2019 |
| APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer S Wang, M Jia, Z He, XS Liu Oncogene 37 (29), 3924-3936, 2018 | 226 | 2018 |
| Sex Differences in Cancer Immunotherapy Efficacy, Biomarkers, and Therapeutic Strategy S Wang, LA Cowley, XS Liu Molecules 24 (18), 3214, 2019 | 133 | 2019 |
| Hiplot: a comprehensive and easy-to-use web service for boosting publication-ready biomedical data visualization J Li, B Miao, S Wang, W Dong, H Xu, C Si, W Wang, S Duan, J Lou, Z Bao, ... Briefings in bioinformatics 23 (4), bbac261, 2022 | 118 | 2022 |
| Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes S Wang, H Li, M Song, Z Tao, T Wu, Z He, X Zhao, K Wu, XS Liu Plos Genetics 17 (5), e1009557, 2021 | 80 | 2021 |
| UCSCXenaShiny: an R/CRAN package for interactive analysis of UCSC Xena data S Wang, Y Xiong, L Zhao, K Gu, Y Li, F Zhao, J Li, M Wang, H Wang, ... Bioinformatics 38 (2), 527-529, 2022 | 77 | 2022 |
| The predictive power of tumor mutational burden in lung cancer immunotherapy response is influenced by patients’ sex S Wang, J Zhang, Z He, K Wu, XS Liu International journal of cancer 145 (10), 2840-2849, 2019 | 65 | 2019 |
| The UCSCXenaTools R package: a toolkit for accessing genomics data from UCSC Xena platform, from cancer multi-omics to single-cell RNA-seq S Wang, XS Liu Journal of Open Source Software 4 (40), 1627, 2019 | 55 | 2019 |
| Sigflow: an automated and comprehensive pipeline for cancer genome mutational signature analysis S Wang, Z Tao, T Wu, XS Liu Bioinformatics 37 (11), 1590-1592, 2020 | 32 | 2020 |
| Ras downstream effector GGCT alleviates oncogenic stress Z He, S Wang, Y Shao, J Zhang, X Wu, Y Chen, J Hu, F Zhang, XS Liu Iscience 19, 256-266, 2019 | 13 | 2019 |
| Copy number signature analyses in prostate cancer reveal distinct etiologies and clinical outcomes S Wang, H Li, M Song, Z He, T Wu, X Wang, Z Tao, K Wu, XS Liu MedRxiv, 2020.04. 27.20082404, 2020 | 9 | 2020 |
| Quantification of neoantigen-mediated immunoediting in cancer evolution T Wu, G Wang, X Wang, S Wang, X Zhao, C Wu, W Ning, Z Tao, F Chen, ... Cancer Research 82 (12), 2226-2238, 2022 | 7 | 2022 |
| Pan-cancer noncoding genomic analysis identifies functional CDC20 promoter mutation hotspots Z He, T Wu, S Wang, J Zhang, X Sun, Z Tao, X Zhao, H Li, K Wu, XS Liu Iscience 24 (4), 2021 | 7 | 2021 |
| The repertoire of copy number alteration signatures in human cancer Z Tao, S Wang, C Wu, T Wu, X Zhao, W Ning, G Wang, J Wang, J Chen, ... Briefings in Bioinformatics 24 (2), bbad053, 2023 | 6 | 2023 |
| Association of CSMD1 with tumor mutation burden and other clinical outcomes in Gastric Cancer X Wang, S Wang, Y Han, M Xu, P Li, M Ke, Z Teng, P Huang, Z Diao, ... International Journal of General Medicine, 8293-8299, 2021 | 5 | 2021 |
| Can tumor mutational burden determine the most effective treatment for lung cancer patients? S Wang, Z He, X Wang, H Li, T Wu, X Sun, K Wu, XS Liu Lung Cancer Management 8 (4), LMT21, 2019 | 4 | 2019 |
| Revisiting neoantigen depletion signal in the untreated cancer genome S Wang, X Wang, T Wu, Z He, H Li, X Sun, XS Liu bioRxiv, 2020.05. 11.089540, 2020 | 3 | 2020 |
| Deciphering clonal dynamics and metastatic routines in a rare patient of synchronous triple-primary tumors and multiple metastases with MPTevol Q Chen, QN Wu, YM Rong, S Wang, Z Zuo, L Bai, B Zhang, S Yuan, ... Briefings in Bioinformatics 23 (5), bbac175, 2022 | 2 | 2022 |
| Ezcox: an R/CRAN package for cox model batch processing and visualization S Wang, XS Liu, J Li, Q Zhao arXiv preprint arXiv:2110.14232, 2021 | 2 | 2021 |
| Ggct (γ‐glutamyl cyclotransferase) plays an important role in erythrocyte antioxidant defense and red blood cell survival Z He, X Sun, S Wang, D Bai, X Zhao, Y Han, P Hao, XS Liu British Journal of Haematology 195 (2), 267-275, 2021 | 2 | 2021 |
Xue-Song LiuShanghaiTech University在 shanghaitech.edu.cn 的电子邮件经过验证
